Immunic
IMUX
IMUX
59 hedge funds and large institutions have $36.9M invested in Immunic in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.09% more ownership
Funds ownership: 5.49% → 5.58% (+0.09%)
90% less call options, than puts
Call options by funds: $55K | Put options by funds: $545K
Holders
59
Holding in Top 10
–
Calls
$55K
Puts
$545K
Top Buyers
| 1 | +$4.69M | |
| 2 | +$1.27M | |
| 3 | +$989K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$806K |
| 5 |
RI
RTW Investments
New York
|
+$804K |
Top Sellers
| 1 | -$2.52M | |
| 2 | -$931K | |
| 3 | -$885K | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$885K |
| 5 |
CAC
Cowen and Company
New York
|
-$804K |